Bringing you live news and features since 2006 

PCR partners with FINARTIS


Private Client Resources (PCR), a provider of total wealth data aggregation services to ultra-high net worth (UHNW) families and institutions has partnered with FINARTIS, a Swiss-based provider of investment management and risk reporting to major private banks, pensions, and family offices. This collaborative offering will combine PCR’s total wealth aggregation capabilities with FINARTIS’s Prospero365 platform to provide an exceptional customer experience across all types of accounts and investments. 

Together, PCR and FINARTIS will provide a fully connected and digital portfolio lifecycle management (PLM) from enrollment, aggregation, to reconciliation, management, accounting, and reporting. The combining solutions enables clients with a true, multi-currency, multi-asset class experience affording growing number of UHNW clients a complete picture of portfolio exposures and investment risks and delivering full performance attribution, comprehensive cash flow projections and risk monitoring for equities, fixed income, hedge funds, private equity, real estate, and real asset investments. 

Automating the consolidation of information from the complex holdings of UHNW investors has long been a challenge for banks, advisors and family offices. With 50 per cent of UHNW holdings often in hard-to-aggregate illiquid investments, the systems that account for and analyse portfolios often rely on manual, error-prone processes. This partnership will ensure that clients have one-hundred percent confidence in their data and reports across all investment strategies and products.

“We are excited to be partnering with FINARTIS to offer their clients a complete aggregation and reconciliation solution while expanding our global footprint and introducing our unique “Privacy First” to the European market,” says Robert Miller, CEO of PCR. “We believe FINARTIS has a differentiated approach of delivering a holistic data-driven experience that helps bankers and investors significantly improve their vision of their investments and risks within their portfolios.”

“We are thrilled about working with PCR,” says Jean-Luc Freymond, Founder and CEO of FINARTIS. “Many firms and institutions today are struggling with aggregating disparate investment data and producing comprehensive and meaningful reporting, forecasts, and analysis for their entire investment portfolio of liquid and alternative investments. We are excited about closing this significant gap that exists in the marketplace by collaborating to roll out this compelling offering and to enter the U.S. market with a mature platform built on years of Swiss Banking knowledge.” 

Bob Miller adds, “The vertically integrated ability of PCR and FINARTIS represents one of the more innovative solutions to facilitate data exchange between liquid asset and illiquid private market programs and investors.” 

Latest News

European ETFs raised USD47.8 billion in Q1, a 15 per cent increase compared to the same period in 2023, according..
LSEG Lipper’s March report finds that globally equity ETFs (+EUR113.2 billion) enjoyed the highest estimated net inflows for the month,..
Morningstar has published a review of the European ETF market for the first quarter 2024, which finds that it gathered..
ETF data consultant ETFGI reports that assets invested in the global ETF industry reached a new record of USD12.71 trillion..

Related Articles

Kristen Mierzwa, FTSE Russell
Index Investments Group (IIG), a division within index provider FTSE Russell, has extended its range of indices through two new...
US ETF issuers of active ETFs are facing an increase in fees from the big custodian firms, such as Charles...
Taylor Krystkowiak, Themes ETFs
Themes ETFs opened its doors in December 2023, with an introductory suite of 11 ETFs – seven thematic and four...
Konrad Sippel, Solactive
At the end of March, financial index specialist, Solactive, published its 2024 annual report on future trends.  ...
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by